All patients with diabetes should have annual UACR tests. Why is that so hard?

Alice Willison (Lead / Corresponding author), Vicki Tully, Peter Davey

Research output: Contribution to journalArticle

60 Downloads (Pure)

Abstract

The urine albumin creatinine ratio (UACR) detects abnormal levels of protein in the urine and should be performed annually to detect kidney disease in patients with diabetes mellitus. UK national audits show that 25% of patients do not have annual tests and our data suggested that some patients had more than one test per year. Data from 20 patients showed that 55% had more than one UACR test per year, with a total of 19 unnecessary tests at an estimated cost of £20,000 per year. However 20% had not had a UACR in the previous year, so unreliable testing was potentially causing harm as well as waste. Process mapping showed that having a UACR test depended on whether the patient brought a urine sample to the clinic. Most (72%) patients were unaware that the urine sample was used to detect kidney damage. We encountered barriers when finding a process to automate measures of reliability of UACR testing using computer protocol, and therefore created a patient information leaflet. The first version of the leaflet was too technical and several changes were suggested by patients. After reading the revised leaflet 99% of patients understood the reason for UACR testing and 64% felt more motivated to bring in urine samples. The phlebotomist disseminated the patient information leaflet with a median of 90% reliability for six consecutive clinics. The patient information leaflet has the potential to improve patient involvement in their care and to increase the number of patients who bring urine samples to the clinic. However, this could increase the number of unnecessary tests unless the process of test ordering is changed to ensure that UACR is only measured annually.

Original languageEnglish
Number of pages6
JournalBMJ Quality Improvement Reports
Volume5
Issue number1
DOIs
Publication statusPublished - 20 Sep 2016

Fingerprint

Albumins
Creatinine
Urine
Patient Participation
Kidney Diseases
Reading
Diabetes Mellitus
Kidney
Costs and Cost Analysis

Cite this

@article{2be579f0d30540e1883a58fa6d45a5e4,
title = "All patients with diabetes should have annual UACR tests. Why is that so hard?",
abstract = "The urine albumin creatinine ratio (UACR) detects abnormal levels of protein in the urine and should be performed annually to detect kidney disease in patients with diabetes mellitus. UK national audits show that 25{\%} of patients do not have annual tests and our data suggested that some patients had more than one test per year. Data from 20 patients showed that 55{\%} had more than one UACR test per year, with a total of 19 unnecessary tests at an estimated cost of £20,000 per year. However 20{\%} had not had a UACR in the previous year, so unreliable testing was potentially causing harm as well as waste. Process mapping showed that having a UACR test depended on whether the patient brought a urine sample to the clinic. Most (72{\%}) patients were unaware that the urine sample was used to detect kidney damage. We encountered barriers when finding a process to automate measures of reliability of UACR testing using computer protocol, and therefore created a patient information leaflet. The first version of the leaflet was too technical and several changes were suggested by patients. After reading the revised leaflet 99{\%} of patients understood the reason for UACR testing and 64{\%} felt more motivated to bring in urine samples. The phlebotomist disseminated the patient information leaflet with a median of 90{\%} reliability for six consecutive clinics. The patient information leaflet has the potential to improve patient involvement in their care and to increase the number of patients who bring urine samples to the clinic. However, this could increase the number of unnecessary tests unless the process of test ordering is changed to ensure that UACR is only measured annually.",
author = "Alice Willison and Vicki Tully and Peter Davey",
year = "2016",
month = "9",
day = "20",
doi = "10.1136/bmjquality.u209185.w3747",
language = "English",
volume = "5",
journal = "BMJ Quality Improvement Reports",
issn = "2050-1315",
number = "1",

}

All patients with diabetes should have annual UACR tests. Why is that so hard? / Willison, Alice (Lead / Corresponding author); Tully, Vicki; Davey, Peter.

In: BMJ Quality Improvement Reports, Vol. 5, No. 1, 20.09.2016.

Research output: Contribution to journalArticle

TY - JOUR

T1 - All patients with diabetes should have annual UACR tests. Why is that so hard?

AU - Willison, Alice

AU - Tully, Vicki

AU - Davey, Peter

PY - 2016/9/20

Y1 - 2016/9/20

N2 - The urine albumin creatinine ratio (UACR) detects abnormal levels of protein in the urine and should be performed annually to detect kidney disease in patients with diabetes mellitus. UK national audits show that 25% of patients do not have annual tests and our data suggested that some patients had more than one test per year. Data from 20 patients showed that 55% had more than one UACR test per year, with a total of 19 unnecessary tests at an estimated cost of £20,000 per year. However 20% had not had a UACR in the previous year, so unreliable testing was potentially causing harm as well as waste. Process mapping showed that having a UACR test depended on whether the patient brought a urine sample to the clinic. Most (72%) patients were unaware that the urine sample was used to detect kidney damage. We encountered barriers when finding a process to automate measures of reliability of UACR testing using computer protocol, and therefore created a patient information leaflet. The first version of the leaflet was too technical and several changes were suggested by patients. After reading the revised leaflet 99% of patients understood the reason for UACR testing and 64% felt more motivated to bring in urine samples. The phlebotomist disseminated the patient information leaflet with a median of 90% reliability for six consecutive clinics. The patient information leaflet has the potential to improve patient involvement in their care and to increase the number of patients who bring urine samples to the clinic. However, this could increase the number of unnecessary tests unless the process of test ordering is changed to ensure that UACR is only measured annually.

AB - The urine albumin creatinine ratio (UACR) detects abnormal levels of protein in the urine and should be performed annually to detect kidney disease in patients with diabetes mellitus. UK national audits show that 25% of patients do not have annual tests and our data suggested that some patients had more than one test per year. Data from 20 patients showed that 55% had more than one UACR test per year, with a total of 19 unnecessary tests at an estimated cost of £20,000 per year. However 20% had not had a UACR in the previous year, so unreliable testing was potentially causing harm as well as waste. Process mapping showed that having a UACR test depended on whether the patient brought a urine sample to the clinic. Most (72%) patients were unaware that the urine sample was used to detect kidney damage. We encountered barriers when finding a process to automate measures of reliability of UACR testing using computer protocol, and therefore created a patient information leaflet. The first version of the leaflet was too technical and several changes were suggested by patients. After reading the revised leaflet 99% of patients understood the reason for UACR testing and 64% felt more motivated to bring in urine samples. The phlebotomist disseminated the patient information leaflet with a median of 90% reliability for six consecutive clinics. The patient information leaflet has the potential to improve patient involvement in their care and to increase the number of patients who bring urine samples to the clinic. However, this could increase the number of unnecessary tests unless the process of test ordering is changed to ensure that UACR is only measured annually.

U2 - 10.1136/bmjquality.u209185.w3747

DO - 10.1136/bmjquality.u209185.w3747

M3 - Article

VL - 5

JO - BMJ Quality Improvement Reports

JF - BMJ Quality Improvement Reports

SN - 2050-1315

IS - 1

ER -